Testing effectiveness (Phase 2)Looking for participantsNCT07245069
What this trial is testing
Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Who this might be right for
Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)+2 more
University Medical Centre Ljubljana 100